OmegAD (Omega-3 and Alzheimer's Disease)
NCT00211159
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
204
Enrollment
OTHER
Sponsor class
Conditions
Alzheimer's Disease
Interventions
DRUG:
EPAX 1050TG
Sponsor
Karolinska University Hospital